Cbot — Merger or Acquisition (June 2007)
29 slides from Cbot's merger presentation, Jun 22, 2007
Slide 1: CBOT/CME: A Combination to Compete Successfully in the Global Marketplace
CBOT/CME: A Combination to Compete Successfully in the Global Marketplace June 21, 2007 Presentation to ISS
Slide 2: Forward-looking statements and important merger information
JUNE 2007 Certain statements in this presentation may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of and includes any use of the words “may,” “should,” “could,” “expects,” “plans,” “anticipates,” “believes,” “estimates,” “predicts,” “potentia
Slide 3: Chicago Board of Trade
@ Chicago Boardof Trade SS Vv VIV
Slide 4: Intensifying global competition among futures, cash and over-the-counter markets
Intensifying global competition among futures, cash and over-the-counter markets Industry Trends Globalization Rapid international growth Technological advances Increased trading speed Shifts in production and consumption Industry consolidation
Slide 5: Global Futures & Options Contract Volume and Secular Growth Drivers
2.1 2.6 3.4 4.0 4.6 6.1 Global Futures & Options on Futures Contract Volume Secular Growth Drivers Large, Expanding Market Strong Secular Trends Source: Futures Industry Association Note: Excludes options on individual equities (Billions of contracts) Technological Advances Globalization Emerging Ec
Slide 6: CBOT's Platform
CBOT’s Platform Leading Futures and Options-on-Futures Exchange Global liquidity provider via electronic and / or open- auction platforms Serves large, growing markets Sophisticated market participants Four broad product groups: Interest Rate Agricultural Equity Index Metals, Energy, and Other
Slide 7: Powerful Business Model - Producing Solid Results
Diverse and High Quality Product Set Global Reach Leading Market Position Common Clearing Link Hybrid Market Structure Proven Track Record and Significant Operating Leverage Powerful Business Model - Producing Solid Results
Slide 8: Strong Operating Leverage: Record Volume and Earnings
7% 20% 31% 20% 28% 44% 40% 48% 1,037 1,365 1,804 2,372 2,677 3,211 3,866 3,108 1,000 1,500 2,000 2,500 3,000 3,500 4,000 1Q06 1Q07 0% 25% 50% 75% Average Daily Volume (000's) Operating Margin (%) Strong Operating Leverage: Record Volume and Earnings Item 2001-2006 CAGR Avg. Daily Volume 25% Revenues
Slide 9: Chicago Board of Trade
© Chicago Boardof Trade ——— eee VV IV |v
Slide 10: Transaction terms: dividend, exercise rights, closing, accretion, ownership
Dividend: Exercise Rights: Anticipated Closing: Expected Accretion: Consideration: Board of Directors: Pro Forma Ownership: All CBOT stockholders would receive a cash dividend of $9.14 per share of Class A common stock if the CBOT/CME merger closes The right to continue as a class member in the CBOE
Slide 11: Board Structure and Transaction Committees
Board Structure and Transaction Committees CBOT Holdings Board 17 directors 11 directors are parent directors elected exclusively by holders of Class A common stock 6 directors are subsidiary directors elected exclusively by a voting trust which holds the Class B common stock and is obligated to ele
Slide 12: Overview of Special Committees
Overview of Special Committees Two separate committees, comprised of independent and disinterested directors Special Transaction Committee Jackie Clegg, Managing Partner, Clegg International Consultants, LLC Larry G. Gerdes, Chairman, President & Chief Executive Officer, Transcend Service s, Inc. No
Slide 13: Special Committees: Process
Special Committees: Process Actively participated in negotiations with CME Financial aspects of the transaction Drafting of the merger agreements Completed comprehensive and independent evaluation of ICE proposal Participated in due diligence review of ICE, including attending due diligence meetings
Slide 14: Timeline
Timeline Oct. 17: Announce initial merger agreement March 15: Receive unsolicited proposal from ICE March 19: Boards authorize discussions with ICE Teams and processes established to review ICE bid Meetings and document review begin March 25-April 27: Thorough due diligence review of ICE, including
Slide 15: Factors Considered by Boards
Factors Considered by Boards Long term shareholder value Potential synergies Risks to franchise Integration and execution risk, especially clearing and technology Competitive dynamics Future growth opportunities and strategic fit Access to new products Globalization Customer and market Ability to cr
Slide 16: Chicago Board of Trade
© Chicago Boardof Trade ST Viv iv v
Slide 17: CME/CBOT: A Strategic Fit
CME/CBOT: A Strategic Fit Creates world’s largest futures exchange Clearly aligned with CBOT’s strategic vision Better positioned to pursue immediate and long-term growth opportunities Entails low integration and execution risk Generates substantial synergy potential
Slide 18: CME Combination Aligned with CBOT Strategic Vision
CME Combination Aligned with CBOT Strategic Vision Expands access to global markets Offers innovative new trading opportunities Enhances depth and breadth of liquidity that we provide the marketplace Provides long-term value to stockholders Ability to close deal quickly and focus on strategic growth
Slide 19: Better Positioned for Immediate and Long-Term Growth Opportunities
Can immediately pursue OTC growth opportunities Greater diversity of revenues Complementary products create opportunities for significant revenue/growth synergies Financials, equities and agricultural products Both organizations have proven track record of long-term growth Better Positioned for Imme
Slide 20: Entails Low Integration and Execution Risk
Entails Low Integration and Execution Risk Builds on strong productive relationship between CME and CBOT over many years CME and CBOT have proven track record in integration Successful integration of CCL in 9 months CME integration of NYMEX in 2 months Speed to integration Migration to Globex expect
Slide 21: Substantial Synergy Potential: Realizable & Certain
Cost synergies of $150 million already identified Includes technology, trading floor consolidation and administrative Expected to be accretive to earnings on a cash basis within 12 months and on a GAAP basis within 12-18 months Share repurchase expected to provide additional earnings accretion Oppor
Slide 22: Opportunities for Significant Revenue Synergies
Opportunities for Significant Revenue Synergies Cross-Selling • Product complementarities significantly increase cross selling opportunities Product Innovation • Yield curve products • Spread products/functionalities • Strong entry point for credit, corporate bond and cash treasury markets Large Sca
Slide 23: Chicago Board of Trade
© Chicago Boardof Trade ST VWVvV Vv
Slide 24: Combination with ICE Presents Significant Risks
Combination with ICE Presents Significant Risks Franchise Risk – Integration and Execution Electronic trading and clearing migration will take at least 24 months, with timeline labeled as “aggressive” and subject to “many risks” by CSC Consulting Expiration of existing service agreements not aligned
Slide 25: Integration Risk – Missed Opportunities
Integration Risk – Missed Opportunities Product development may be adversely affected during migration to ICE platform Loss of critical personnel anticipated during migration creates additional risk for business Protracted integration process would put CBOT at competitive disadvantage in a rapidly c
Slide 26: Significant Integration Risk With ICE
6,454 741 3,866 3,866 Significant Integration Risk With ICE ICE’s current trading and clearing platforms do not have the capacity to serve our volume and business model ( i.e. , functionality) Necessary changes in these systems must be properly designed, funded and timely implemented Failure to achi
Slide 27: Equity Research Highlights the Strategic and Operational Advantages of a CME Transaction
Equity Research Highlights the Strategic and Operational Advantages of a CME Transaction . . . Howard Chen, Credit Suisse (May 30 – June 14) “ We ’ ve supported this deal given its strategic fit and more limited integration/execution risk – that hasn’t changed . ” “ Integration/execution risk remain
Slide 28: And Believes the CME Transaction Should Prevail
. . . And Believes the CME Transaction Should Prevail Edward Ditmire, Fox-Pitt (June 13) “We believe a minority of CBOT members are strictly focused on price, and ICE likely already had their support, but most are weighing integration risk against price, and this balan ce hasn't changed much. ” Niam
Slide 29: CME/CBOT: A Strategic Fit
CME/CBOT: A Strategic Fit Creates world’s largest futures exchange Clearly aligned with CBOT’s strategic vision Better positioned to pursue immediate and long term growth opportunities Entails low integration and execution risk Generates substantial synergy potential